AIMS 2025: Emmanuel J Favaloro’s Haemostasis Tour Hits Finale
Emmanuel J Favaloro, Lead Scientist at Sydney Centres for Thrombosis and Haemostasis, Westmead Hospital, posted on LinkedIn:
”Just completed my final session as the Australian Institute of Medical and Clinical Scientists (AIMS) 2025 Travelling Orator, in Adelaide for the South Australian (SA)/Northern Territory (NT) Branch. A well organised and well attended (pre-)Christmas meeting where I spoke on the topic of “Advances in Haemostasis”. This assignment has been an honour for me.
In total, 6 different venues, with 11 presentations, covering all states and territories in Australia (bar Queensland and the ACT). In total, around 500 attendees, both young and not so young.
Hope to be selected again before I hang up my haemostasis hat for good.”
Stay updated with Hemostasis Today.
-
Aug 6, 2026, 01:21Orly Leiva: High-Output Heart Failure Signals Disease Progression in PV and ET
-
Aug 5, 2026, 23:46Recommended ESC Congress Sessions for the ESC Working Group on Thrombosis
-
Aug 5, 2026, 23:36Heghine Khachatryan: ISTH Day 2 – Phase III VAYHIT2 Data Highlights Ianalumab in Primary ITP
-
Aug 5, 2026, 23:28Basyouni Omran: KDIGO 2025/2026 Bedside Guide – Iron Correction in CKD
-
Aug 5, 2026, 23:13C. Michael Gibson: Jean Connors on Antithrombotic Therapy for LVAD at Baim Grand Rounds
-
Aug 5, 2026, 23:07Building Safer Systems for Bleeding and Clotting Care with Dr. Toyosi Onwuemene
-
Aug 5, 2026, 21:19Vidhi Shukla: Anticoagulant Activity of Ficus Racemosa Bark Extract in Rats
-
Aug 5, 2026, 20:30Denis Oduor: Patient Blood Management and Systemic Transfusion Reform
-
Aug 5, 2026, 20:15Salih Ehsan: Diagnostic Screening Strategy for Hemoglobinopathy Traits